[Is stairclimbing a maximal exercise test for COPD patients?].

Rev Mal Respir

Service de pneumologie, CHU Saint-Pierre, EFR-322, rue haute, 1000 Bruxelles, Belgique.

Published: September 2014

Introduction: Variable tests evaluate the cardio-respiratory working capacity of COPD patients. Stairclimbing testing has been less studied. Our hypothesis is that this functional exercise test represents a submaximal effort for these patients.

Method: We compared in 10 COPD patients the main metabolic and ventilatory parameters at the end of an effort between stairclimbing and cycle ergometer test.

Results: The following parameters studied (RER, V'CO2, lactates, V'E) are significantly lower for stair climbing. Nevertheless, in 8 patients, the V'O2 at the end of the stairclimbing testing is equal to the cycle ergometer test and in two patients superior. Concerning the evolution of some parameters during stairclimbing, 2 distinct profiles were observed: stabilization of the V'O2, HR, V'E and Vt (6/10 patients) or a constant increase of those parameters (4/10 patients).

Conclusion: Stairclimbing represents a submaximal effort for the majority of COPD patients combined with a high metabolic cost. However, some COPD patients execute a maximal effort like in the cycle ergometer test when climbing stairs. These two groups could not be differentiated with the rest lung function data. The hypothesis of different mechanical constraints and/or motivation is suggested.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmr.2013.09.016DOI Listing

Publication Analysis

Top Keywords

copd patients
16
cycle ergometer
12
exercise test
8
stairclimbing testing
8
represents submaximal
8
submaximal effort
8
ergometer test
8
patients
7
copd
5
stairclimbing
5

Similar Publications

Introduction Chronic obstructive pulmonary disease (COPD) is a significant contributor to global morbidity and mortality. Despite well-established management protocols, treatment remains suboptimal due to high costs and mortality rates. This study aims to compare the impact of initial oxygenation status, Dyspnea, Eosinopenia, Consolidation, Acidemia, and Atrial Fibrillation (DECAF), and National Early Warning Score 2 (NEWS2) scores on management outcomes in COPD patients.

View Article and Find Full Text PDF

Results from a UK consensus about the optimal prescribing of medium strength triple therapy in uncontrolled adult asthma patients in the NHS.

J Family Med Prim Care

December 2024

Medicines Evaluation Unit, Manchester University National Health Service Foundation Trust, University of Manchester, Manchester, United Kingdom.

Context: An inhaled corticosteroid (ICS) in combination with a long-acting β2-agonist (LABA) is a common treatment approach for asthma patients not controlled on ICS alone, but a significant proportion of patients remain uncontrolled on this combination and treatment adherence can also be a challenge. One of the options for adults whose asthma is uncontrolled in an ICS/LABA is the addition of a long-acting muscarinic receptor antagonist (LAMA), an approach commonly referred to as 'triple therapy'. The use of medium-strength ICS/LABA/LAMA is established in treating chronic obstructive pulmonary disease but is less well-established in asthma.

View Article and Find Full Text PDF

The patient was a 66-year-old man who developed exacerbation of respiratory and heart failure that necessitated tracheal intubation. The exacerbation was considered to be largely caused by asthma-chronic obstructive pulmonary disease overlap syndrome and type 3 pulmonary hypertension. However, left diaphragmatic eventration and tracheal stenosis were also found.

View Article and Find Full Text PDF

Background: The significance of pulmonary artery (PA) diameter in patients with non-small cell lung cancer (NSCLC) and chronic obstructive pulmonary disease (COPD) who undergo pulmonary resection has not been elucidated.

Methods: Data of 357 patients with NSCLC and COPD who underwent pulmonary resection were retrospectively reviewed. The main PA diameter, determined by preoperative computed tomography, relative to the body surface area (PBR), was used as an index of PA dilatation, and patients were divided into 2 groups using median values.

View Article and Find Full Text PDF

Background: Irrespective of baseline diabetes status, preoperative hemoglobin A1c (A1C) influences perioperative care in patients undergoing metabolic and bariatric surgery (MBS). Accordingly, the American Society of Metabolic and Bariatric Surgery (ASMBS) endorses that patients undergoing MBS should receive a preoperative A1C test. We aimed to assess the proportion of MBS patients who received a preoperative A1C test and determine whether baseline diabetes status influences receipt of a test.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!